On March 27, 2019, Entegris, Inc. (“Entegris”) granted Versum Materials, Inc. (“Versum”) a waiver that permits Versum to engage in discussions with, but not providenon-public information to, Merck KGaA, Darmstadt, Germany (“Merck”) for a10-day period commencing on March 27, 2019. A copy of the waiver letter is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
On March 28, 2019, in accordance with such waiver, representatives of Versum and Merck met to discuss the terms of the previously announced unsolicited tender offer from Merck to acquire all outstanding shares of Versum for $48 per share in cash (the “Offer”) and Merck conveyed the possibility of improving the terms of the Offer upon review by Merck of certain information required for Merck to complete its due diligence.
Following such discussion, on March 29, 2019, Versum issued a press release announcing that the board of directors of Versum (the “Versum Board”), after careful consideration and consultation with its financial and legal advisors, unanimously determined to reject the Offer, unanimously determined that Merck’s proposal could reasonably be expected to result in a superior proposal for purposes of Versum’s previously announced merger agreement with Entegris, and authorized Versum’s management and its advisers to engage in further discussions with, and providenon-public information to, Merck. A copy of the press release is attached hereto as Exhibit 99.2 and is incorporated herein by reference.
The Versum Board has not changed its recommendation in support of the pendingall-stock merger of equals with Entegris.
Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits
Additional Information About the Merck Tender Offer
Versum Materials intends to file a solicitation/recommendation statement with respect to the tender offer with the SEC within 10 business days of the commencement of the tender offer.INVESTORS AND SECURITY HOLDERS ARE URGED TO READ THE SOLICITATION/RECOMMENDATION STATEMENT WITH RESPECT TO THE TENDER OFFER AND OTHER RELEVANT DOCUMENTS THAT ARE FILED WITH THE SEC WHEN THEY BECOME AVAILABLE BECAUSE THEY WILL CONTAIN IMPORTANT INFORMATION ABOUT THE TENDER OFFER. You will be able to obtain free copies of the solicitation/recommendation statement with respect to the tender offer and other documents filed with the Securities and Exchange Commission (“SEC”) by Versum Materials through the website maintained by the SEC at http://www.sec.gov. Copies of the documents filed with the SEC by Versum Materials will be available free of charge on Versum Materials’ website at http://investors.versummaterials.com or by phone at484-275-5907.
Forward-Looking Statements
This communication contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that are subject to risks and uncertainties and are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1993, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. Where a forward-looking statement expresses or implies an expectation or belief as to future events or results, such expectation or belief is expressed in good faith and believed to have a reasonable basis. The words “believe” “continue,” “could,” “expect,” “anticipate,” “intends,” “estimate,” “forecast,” “project,” “should,” “may,”